NC4

Eclat Pharmaceuticals, L.L.C. is a specialty pharmaceutical company based in St. Louis, Missouri, dedicated to developing, approving, and commercializing niche brands and generic products. With a focus on improving patient outcomes, Eclat utilizes its expertise in the regulatory process, development, manufacturing, and distribution to find innovative and cost-effective solutions for drug delivery and side effect profiles. Through its strategic approach, Eclat has identified several promising product opportunities and is actively developing them. With the acquisition by Flamel Technologies SA in 2012, Eclat has become a more vertically integrated company, benefiting from enhanced development and commercial expertise, advanced drug delivery platforms, and increased potential for value creation.Generated from the website